Celularity Inc reports results for the quarter ended in June - Earnings Summary

Celularity

21/08/2023 15:27

* Celularity Inc  CELU.OQ  reported a quarterly adjusted
loss
of 27 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 3 cents per
share.
    * Revenue fell 22.2% to $2.94 million from a year ago;
analysts
expected $26.80 million. 
    * Celularity Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The mean earnings estimate of analysts had risen by
about 86.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Celularity Inc shares had fallen by 40.1% this quarter and
lost 75.3% so far this year.
    * The company reported a quarterly loss of $47.95 million.
    * Wall Street's median 12-month price target for Celularity
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 21 at 02:27 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.03          -0.27          Missed
 Mar. 31 2023      -0.24          -0.41          Missed
 Dec. 31 2022      -0.26          0.16           Beat
 Sep. 30 2022      -0.26          0.03           Beat